FDA Adverse Event
Injury
Summary report: N
FINELINE II
MDR report key: 3213699
·
Received July 9, 2013
Report
- Report Number
- 2124215-2013-08846
- Event Type
- Injury
- Date Received
- July 9, 2013
- Date of Event
- May 22, 2013
- Report Date
- May 22, 2013
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS RIGHT ATRIAL (RA) LEAD WAS UNDERGOING A REPLACEMENT PROCEDURE. IT WAS REPORTED THAT THIS LEAD EXHIBITED HIGH OUT OF RANGE PACING IMPEDANCES GREATER THAN 2,500 OHMS AND WAS FRACTURED. THE LEAD WAS BEING REPLACED WITH A COMPETITOR'S PRODUCT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 314448 | FINELINE II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4470 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Hospitalization| L| R | 4457| S606| 1290| 4470 |